46th Telluride Mushroom Festival

As the functional mushroom industry grows, one thing is becoming increasingly clear: mushrooms from the same species are not necessarily the same in function or chemistry. Across lion’s mane, agarikon, and turkey tail, factors such as strain, substrate, tissue type, and extraction method can meaningfully shape biological activity and functional outcomes.

Drawing from fungal genomics, metabolomics, preclinical transcriptomics, and emerging clinical evidence, this presentation explores how fungal diversity functions not as inconsistency to be eliminated, but as a blueprint for discovery and product innovation. Highlighting the first annotated genome of agarikon alongside a strain library of more than 125 agarikon isolates, the talk examines how strain-level variation drives measurable differences in bioactive composition and downstream functional activity.

In both agarikon and turkey tail, mycelial preparations demonstrate context-dependent activity supported by two placebo-controlled human clinical trials reporting concordant immune-supportive outcomes. Lion’s mane further serves as a model system for understanding how tissue type and extraction approach influence both immune and neuroactive properties.

But as mushroom chemistry becomes more deeply mapped, a larger question emerges: when biomarkers don’t fully explain bioefficacy, we may need to rethink what “functional” actually means for mushrooms. Rather than reducing fungi to single compounds or species-level assumptions, this talk explores a systems-level view of mushrooms where biological complexity becomes a resource for discovery, innovation, and the rewilding of functional mushroom science.

All presentation in Transformation Studio are first come first serve. A line will be formed outside of Ah Haa for this presentation. There will be limited seats so please plan for a different event if this is full.